News

Scientists observed differences in bone marrow mast cell characteristics across different mast cell disorders.

A clinical trial is testing avapritinib and decitabine to improve outcomes for patients with SM and an associated blood cancer.

Research shows a possible link between cold urticaria and cold-induced anaphylaxis with systemic mastocytosis.

Though patients with ISM have a normal life expectancy, they need more health care visits and medications than the general population.

The HARBOR study will compare elenestinib with a placebo and best supportive care to determine its effectiveness in treating ISM.

Because SM is a rare disorder, it is sometimes diagnosed incidentally during unrelated procedures.

AI models analyzed electronic health records to predict which patients may have undiagnosed systemic mastocytosis.

The study highlights the risks of relying on social media for medical advice.

While present in most cases of SM, KIT D816V is not the only diagnostic marker of the disease.

A recent case report provides insight on the management of mast cell leukemia (MCL), a rare systemic mastocytosis (SM) subtype.